Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
Public ClinicalTrials.gov record NCT01401465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Two Period Two-Way Crossover Study To Evaluate Patient Preference, Satisfaction And Efficacy Of A Nasal Aerosol Versus An Aqueous Nasal Spray Used For The Treatment Of Allergic Rhinitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, multicenter, 2-way crossover study in subjects 12 years or older with perennial allergic rhinitis (PAR) to evaluate patient preference, satisfaction and efficacy of ciclesonide nasal aerosol versus mometasone aqueous nasal spray. A novel patient-administered assessment, developed and validated to measure patient satisfaction with and preference of intranasal corticosteroids (INCS) for the treatment of allergic rhinitis (AR), is utilized in this study.
Study identification
- NCT ID
- NCT01401465
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 327 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2011
- Primary completion
- Oct 31, 2011
- Completion
- Oct 31, 2011
- Last update posted
- Apr 29, 2013
2011
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Asthma and Allergy Specialists Medical Group | Huntington Beach | California | 92647 | — |
| Southern California Research | Mission Veijo | California | 92691 | — |
| Allergy Associates Medical Group, Inc. | San Diego | California | 92120 | — |
| Allergy & Asthma Medical Group & Research Center, A.P.C. | San Diego | California | 92123 | — |
| Asthma & Allergy Associates, P.C. | Colorado Springs | Colorado | 80907 | — |
| Northeast Medical Research Associates, Inc. | North Dartmouth | Massachusetts | 02747 | — |
| Clinical Research Institute Inc. | Minneappolis | Minnesota | 55402 | — |
| The Clinical Research Center, L.L.C. | St Louis | Missouri | 63141 | — |
| The Asthma and Allergy Center, PC | Bellevue | Nebraska | 68123 | — |
| Princeton Center for Clinical Research | Skillman | New Jersey | 08558 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | 97504 | — |
| Allergy Associates Research Center | Portland | Oregon | 97202 | — |
| Pharmacuetical Research & Consulting, Inc. | Dallas | Texas | 75231 | — |
| Western Sky Medical Research | El Paso | Texas | 79903 | — |
| Sylvania Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01401465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01401465 live on ClinicalTrials.gov.